Ferrichrome: Surprising stability of a cyclic peptide-FeIII complex revealed by mass spectrometry  by Kaltashov, Igor A. et al.
Ferrichrome: Surprising Stability of a Cyclic 
Peptide-Fe”’ Complex Revealed by 
Mass Spectrometry 
Igor A. Kaltashov and Robert J. Cotter 
Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, 
Baltimore, Maryland, USA 
W. Harry Feinstone 
University of Memphis, Memphis, Tennessee, USA 
Gary W. Ketner 
Department of Molecular Microbiology and Immunology, Johns Hopkins University School of Hygiene and 
Public Health, Baltimore, Maryland, USA 
Amina S. Woods 
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 
Ferrichrome, a fungal siderophore that is also utilized by some bacterial species, was studied 
with liquid secondary ion mass spectrometry (LSIMS) and matrix-assisted laser desorption 
ionization (MALDI) mass spectrometry. A strong ionic signal corresponding to a Fe” complex 
was observed with LSIMS in the positive ion mode. Switching the polarity of the mass 
spectrometer did not necessarily result in reduction of ferric ion, although certain conditions 
led to appearance of a Fe” complex signal as well. The results of the structural studies of the 
metal ion-cyclic peptide complex with collisionally induced dissociation allowed unambigu- 
ous identification of the chelation sites. The action of the siderophore on Fe’” was studied by 
in vitro chelation of ferric ion (from ferric citrate) by the iron-free ferrichrome. Effective 
chelation of ferric ion was compared to actions of the iron-free ferrichrome on other metal ions. 
Unlike LSIMS, desorption with MALDI did not form selectively molecular ions of intact 
ferrichrome: the spectra contained abundant peaks corresponding to the cyclic peptide itself 
and its nonspecific association with alkali metal ions. (J Am Sot Mass Spectrom 1997, 8, 
1070-1077) 0 1997 American Society for Mass Spectrometry 
I ron is a mineral essential for normal growth of a vast majority of microorganisms [l-3]. Under aerobic conditions the abundance of free iron is limited 
because of the very low solubility of ferric hydroxide. 
To maintain required levels of iron intracellularly, bac- 
teria and fungi, as well as gramineous plants, elaborate 
effective ferric ion chelating agents, called siderophores, 
to scavenge for iron in the extracellular environment 
and transport it inside the microorganism [3, 41. In 
recent years, siderophores began attracting growing 
interest in the medical community, inspired by hopes of 
employing them as effective delivery systems for anti- 
microbial agents [5]. 
Although siderophores can be easily isolated as iron 
chelates in large quantities, structural studies of the 
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intact complexes are quite difficult to perform due to 
the high spin of the ferric ion that leads to broadening 
of ‘H NMR bands. Application of x-ray crystallography 
to structural characterization of siderophores has been 
also somewhat limited owing to the fact that less than a 
half of known siderophores can be crystallized [3, 61. 
Another powerful analytical tool for structure charac- 
terization of siderophores via analysis of electronic state 
of iron ions in such compounds is Mossbauer spectros- 
copy [7]. Mass spectrometry has also been proven to be 
a valuable tool in siderophore structure elucidation, 
although earlier studies of iron-containing phytosider- 
ophores by fast atom bombardment (FAB:) mass spec- 
trometry [8] revealed that a prompt reduction of Fen1 to 
Fe” takes place inside the ion source. This promotes a 
change in the metal ion coordination geometry, render- 
ing impossible a direct determination of chelation sites 
within the complex. 
Ferrichrome, one of the first discovered sid- 
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Figure 1. Chemical structure of ferrichrome [6]. 
erophores, was originally extracted from a rust fungus 
Ustilago sphaerogena [9]. It was found later that the very 
same siderophore, if present in the environment, can 
also be utilized by several bacterial species, including E. 
coli [3]. It is a cyclic peptide containing three glycine and 
three modified ornithine residues, with six oxygen 
atoms employed to chelate Fe”’ (Figure 1). The Fen1 
affinity of ferrichrome is very high, as suggested by a 
rather low reduction potential of the complex, E,,, < 
-0.6 V at pH 8 [lo]. Nevertheless, the binding of the 
metal ion to the cyclic peptide is reversible, and the 
complex dissociates nondestructively (i.e., release of the 
metal ion leaves the peptide intact) inside the fungal cell 
following the reduction of Fe”’ to Fe” [lo]. We report 
here on the results of mass spectral studies of the 
structure of the metal-containing ferrichrome, that re- 
veal a remarkable stability of the complex. 
Experimental 
Materials 
The siderophore was obtained from a field isolate (A31) 
of Aspergillus tentatively identified as A. j7avofircatus. 
For production of the siderophore, A31 cultures were 
grown in minimal medium supplemented with yeast 
extract at 28-30 “C in a well aerated fermenter. Purifi- 
cation was by ion-exchange, reverse-phase, and gel 
filtration chromatography and will be described else- 
where. The siderophore is a potent inhibitor of growth 
of bacteriophages including Tl and $80 [ll], and a 
bacteriophage Tl growth-reduction bioassay was used 
to monitor purification steps. Iron-free ferrichrome 
(from U. sphaerogena), calcium acetate, zinc acetate, and 
ferric citrate were purchased from Sigma Chemical Co. 
(St. Louis, MO). 
Mass Spectromety. LSIMS spectra were acquired on a 
Concept IH (Kratos Analytical, Manchester, UK) two- 
sector (EB geometry) mass spectrometer at a resolution 
of 1000. A I-PL aliquot of sample solution in water was 
mixed with the matrix (3nitrobenzyl alcohol, 3-NBA or 
monothioglycerol, MTG) on the tip of the probe. Ana- 
lyte ions were desorbed from the matrix by an S-keV 
Cs’ primary-ion beam. The mass spectra were acquired 
by scanning the magnet at a 10-s/ decade scan rate. B / E 
linked scans were employed to acquire the spectra of 
the product ions following high-energy collision-in- 
duced dissociation (CID) (Xe, 50% attenuation) of the 
precursor ions in the first field-free region of the mass 
spectrometer. Normally 5-50 scans were averaged for 
each spectrum. 
MALDI time-of-flight (TOF) mass spectra were ac- 
quired on Kompact III (dual-stage reflectron) and 
Kompact IV (curved-field reflectron) TOF mass spec- 
trometers (Kratos Analytical, Manchester, UK). Samples 
were prepared by depositing 0.3 PL of matrix (2,5- 
dihydroxybenzoic acid in methanol) onto the stainless 
steel slide followed by 0.3~PL aliquot of the analyte. 
Analyte ions were desorbed from the matrix with a 
337-nm nitrogen laser irradiation. TOF spectra were 
acquired in a reflectron high voltage mode using 20-kV 
extraction voltage. Each spectrum was an average of 50 
shots. 
Results and Discussion 
Recent advances in mass spectrometry, such as intro- 
duction of the electrospray ionization (ESI) technique, 
allow direct studies of biologically relevant noncovalent 
complexes to be carried in the gas phase [12]. One of 
these studies, which is of particular relevance to the 
topic of the present work, focused on the observation of 
ferric ion complexation with a synthetic analog of a 
bacterial siderophore, ligand L [13]. It must be noted 
that the vast majority of noncovalent complexes, includ- 
ing metal ion-ligand systems, can survive a transition 
from solution to gas phase only under mild conditions 
of electrospray [12]. The attempts to detect complex- 
ation of Fe3+ and Co3+ ions by phytosiderophores 
under harsh conditions of FAB [8] have failed due to 
prompt reduction of these ions to Fe’!+ and Co’+, 
correspondingly. Another group of siderophores, ex- 
ochelins from M. tuberculosis, have been recently stud- 
ied by a combination of LSIMS and electrospray ioniza- 
tion mass spectrometry [14]. While only intact ferri- 
exochelin cations have been detected by ES1 mass 
spectrometry, the LSIMS spectra contained numerous 
cationic species, including chelates of Na, Mgn, Al’“, 
Fe”‘, as well as uncomplexed analyte cations [14]. 
The LSIMS spectrum of the iron-free ferrichrome is 
presented on Figure 2a. The most abundant peak at m / z 
688.2 corresponds to a protonated pepbide ion [M + 
HI+. The intact ferrichrome molecule does not carry a 
net electrical charge at neutral pH, because the positive 
charge of Fe” is compensated by a net negative charge 
of the oxygen atoms of the cyclic peptide (M) modified 
ornithine side chains, the monoisotopic molecular 
weight of this neutral intact species [M-3H + Fen’]o 
being 740.2 amu. To be detected with a mass spectrom- 
eter, this complex must be protonated or canonized by 
an alkali metal ion. Figure 2b shows the positive ion 
LSIMS spectrum of ferrichrome. The most abundant 
ions correspond to [M-2H + Fe’“]+ (at m/z 741.0) and 
[M-3H + Fe”’ + Na]+ (at m/z 763.0). Int’erestingly, no 
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Figure 2. Positive ion LSIMS spectra of ferrichrome: (a) iron-free peptide and (b) HPLC-purified 
complex. 
signal corresponding to either protonated ([M + HI+ at 
m/z 688.3) or sodiated ([M + Na]+ at m/z 710.3) 
peptide lacking ferric ion has been observed, nor could 
be detected any ionic signal corresponding to iron 
(Fe”+, n = l-3) escaping its carrier. 
To study the chelation and solubilization of ferric 
ions by molecules of the iron-free ferrichrome, ferric 
citrate was added to a 1-mg/mL solution of the sid- 
erophore (in 50% methanol). No color change of the 
solution was visible following precipitation of the salt. 
The positive ion LSIMS spectrum of the supernatant of 
the suspension was recorded immediately following the 
addition of ferric citrate. No signal of a Fe”‘-peptide 
complex was detected at that time; the spectrum ap- 
peared to be an exact replica of that presented in Figure 
2a. The peptide-ferric citrate mixture was then soni- 
cated in an ultrasonic bath at room temperature, and 
aliquots of the supernatant were analyzed following 
lo-min, 30-min, and l-h time intervals. The resultant 
mass spectra (Figure 3) show consistent increase of the 
content of the metal ion-cyclic peptide complex; the 
ionic signal of the uncomplexed peptide, [M + HI+, is 
not present in the final spectrum (Figure 3~). 
To compare complexation of Fe”’ by ferrichrome 
with other metals, excess calcium acetate and zinc 
acetate were added to solutions of the iron-free fer- 
richrome in quantities enough to saturate the solutions 
with the salts. Both mixtures were mass analyzed 
following a 30-min sonication period (Figure 4). The 
peptide has been found to chelate Cazf ions, as re- 
flected by the appearance of abundant [M-H + Ca”]+ 
and [M-3H + 2Can]+ ions in the spectrum. However, 
metal-free peptide cation [M + Hjf is always present in 
the spectrum, suggesting that Car’ affinity of fer- 
richrome is lower compared to its Fe”’ affinity. Almost 
no ions corresponding to Zn” adducts can be observed 
in the spectrum of the iron-free ferrichrome/zinc ace- 
tate mixture (Figure 4b). The striking difference in the 
complexation behavior of Ca” and Zn” probably re- 
flects the fact that the Zn2’ ion is a soft acid (unlike 
Ca2+ and Fe3+), and therefore binds much weaker to 
oxamide (which is a hard base). 
Further insight on the structure of ferrichrome ions 
and their relevance to the structure of intact metal- 
ligand complex can be provided by methods of tandem 
mass spectrometry. Collision-induced dissociation of 
specific peptide-metal ion complexes has shown a 
promise of being able to provide valuable information 
on the location of the chelation sites fl5]. In the present 
work, both intact and iron-free ferrichrome cations, 
[M-2H + Fe”‘]+ and [M + H]+ have been subjected to 
high-energy CID. The most abundant high-mass frag- 
ment ions in the spectrum of the dissociation of the 
iron-free ferrichrome cation (Figure 5a) are .those due to 
the loss of H,O, (OC)CH,, and CO. The latter one is a 
typical “ring-opening” fragment, which is characteristic 
for all cyclic peptides 1161. The loss of (OC)CH, may 
also result from a ring-opening process [16], as well as 
from the cleavage of labile amide bond at the side 
chains of modified omithine residues. Most other peaks 
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Figure 3. Solubilization of iron by ferrichrome: positive ion LSIMS spectra of iron-free ferrichrome 
sonicated with an excess of ferric citrate for (a) 10 min, (b) 30 min and (c) 1 h. 
in the spectrum correspond to ring-opening processes 
resulting from elimination of one or more amino acid 
residues. 
Not surprisingly, all fragments of the intact fer- 
richrome cation, [M-2H + Fe”‘]+, observed in the CID 
spectrum (Figure 5b), contain ferric ion (all others are 
very unlikely to be detected, since a departure of Fe”’ 
from a singly charged precursor ion would most likely 
change the polarity of the resulting fragment). To 
simplify the interpretation of both CID spectra we have 
shifted the mass-to-charge ratio scale of the intact 
ferrichrome cation CID spectrum (Figure 5b) to higher 
masses by 53 amu (%Fe-3’H). The dotted lines on Figure 
5 show the pairs of matching peaks, Mg and [Mf,-3H + 
Fer”] + , corresponding to analogous fragment ions 
present in both spectra. Our attention, however, has 
been directed mostly towards the “unmatched” frag- 
ment ion peaks, because those may provide information 
on how the fragmentation of the cyclic peptide is 
affected by the presence of Fen’. This information can be 
used to determine the location of the ferric ion chelation 
sites within the siderophore unaffected by the solvent. 
The most noticeable difference between the two CID 
spectra is the absence of the fragment ions due to the 
loss of ketene moiety CHJCO) in the CID spectrum of 
the intact ferrichrome cation (Figure 5b). This fact may 
be rationalized by assuming that the major process 
leading to the loss of ketene in the iron-free ferrichrome 
cations is a cleavage of a labile hydroxamide bond. This 
dissociation process may have a significantly lower rate 
constant for the metal ion-peptide complex if the hy- 
droxamate groups of the peptide become involved in 
ligation of the ferric ion. 
Both CID spectra on Figure 5 contain ifragment ion 
peaks associated with ring-opening processes resulting 
in losses of one or more glycine or ornithine amino acid 
residues. However, the fragment ions resulting from 
the loss of the two ornithine residues from a metal- 
containing cation, [OmGlya-H,O-2H + Fern] ‘- or [OrnGly,- 
H,O-H + Fe”‘]‘-+, were not detected among the CID 
products of [M-2H + Fe”‘]+ (Figure 5b), whereas a 
prominent fragment ion peak [OrnGlya-HZ0 + H]+ is 
present in the CID spectrum of the iron-free peptide 
cation (Figure 5a). This indicates the inability of a single 
hydroxamate to coordinate Fe”’ effectively. Interest- 
ingly, very prominent fragment ions resulting from the 
loss of one ornithine residue are present in CID spectra 
of both intact and iron-free ferrichrome cation. This 
suggests that a minimal amount of two hydroxamates is 
required to maintain a stable Fe”’ coordination complex 
in the gas phase. Abundant fragment ions resulting 
from the consecutive elimination of all glycine residues 
are also present in both CID spectra, suggesting that 
heteroatoms of the peptide backbone do not play any 
significant role in the complexation of the ferric ion. 
In the negative ion mode, a reduction of Fe”’ to Fe” 
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Figure 4. Complexation of Zn” and Ca” by ferrichrome: positive ion LSIMS spectra of iron-free 
ferrichrome incubated with (a) zinc acetate and (b) calcium acetate. 
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Figure 5. High-energy CID fragment ion spectra of a protonated iron-free ferrichrome cation [M + 
H]+ at m/z 688.2 (a) and a metal ion-peptide cationic complex [M-2H + Fen’]+ at m/z 741.0 (b). 
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Figure 6. Negative ion LSIMS spectra of ferrichrome: HPLC-purified metal ion-peptide complex 
using (a) 3-NBA and (b) MTG as matrices, and (c) an iron-free peptide using MTG as a matrix. Inserts: 
calculated isotopic distributions for ferrichrome anions containing Fe”’ and Fe”. 
was expected to take place. Indeed, when 3-NBA was 
employed as a matrix, a mixture of the two oxidation 
states has been detected, corresponding anions being 
separated by 1 amu (Figure 6a). These correspond to 
[M-4H + Fe”‘]- (calculated molecular weight 739.2 
amu, measured 739.3 amu) and [M-3H + Fe”]- (calcu- 
lated molecular weight 740.2 amu, measured 740.3 
amu) anions. Interestingly, the reduction does not take 
place when another matrix, MTG, is used to desorb 
ferrichrome anions: the measured isotopic distribution 
for the most prominent peak in the spectrum is very 
close to calculated natural isotopic distribution for the 
Fe”‘-containing anion (Figure 6b). The most likely rea- 
son for the different redox behavior of the two matrices 
is the fact that under LSIMS conditions MTG tends to 
form an even-electron (deprotonated) anion, while 3- 
NBA forms predominantly an odd-electron anion (rad- 
ical ion), which may promote reduction of the peptide- 
bound ferric ion: 
NBA’- + [M-3H + Fe”‘]’ $ NBA’ + [M-3H + Fe”]- 
The enzymatic reduction of the ferric ion to ferrous ion 
within a hydroxamate-based siderophore is a precursor 
to an intracellular release of iron [4]. However, our data 
indicate that reduction of Fe”’ to Fe” does not lead to a 
prompt dissociation of the metal ion from the peptide: 
the iron-free anions of ferrichrome, [M-H]-, have not 
been detected in any of the negative ion LSIMS spectra 
of the high-performance liquid chromatography 
(HPLC)-purified ferrichrome, even in the presence of a 
strong ionic signal of a peptide-ferrous -ion complex 
(Figure 6a). It is possible that other factors (such as the 
solution pH) may contribute to the surprising stability 
of this partially reduced metal ion-peptide complex. 
High-energy CID spectra of both iron-free and Fe”‘- 
containing ferrichrome anions have been also acquired 
on a sector instrument (Figure 7). The striking differ- 
ence between the two spectra provides add.itional infor- 
mation on the location of the ferric ion within the 
peptide. First, the most abundant fragment ion in the 
CID spectrum of [M-H]- is due to the loss of water, i.e., 
[M-H,O-HI-, whereas the most prominent peak in the 
CID spectrum of an intact ferrichrome anion, [M-4H + 
Fe”‘]-, results from the loss of ammonia, i.e., [M-NH,- 
4H + Fe”‘]-. The loss of ketene gives rise to a promi- 
nent peak in the CID spectrum of the iron-free fer- 
richrome anion, while the relative intensity of the 
analogous peak in the CID spectrum of the intact 
ferrichrome is significantly lower. 
The only prominent peak present in both spectra, 
that is associated with the loss of an amino acid residue, 
results from elimination of two glycine residues. None 
of the fragments, resulting from elimination of one or 
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Figure 7. High-energy CID fragment ion spectra of deprotonated iron-free ferrichrome anion 
[M-H]- at M/Z 686.3 (a) and a metal ion-peptide anionic complex [M-4H + Fe”]- at m/z 739.1 (b). 
m/Z 
more ornithine residues, is present in the CID spectrum 
of the intact ferrichrome anion (Figure 3~). Another 
interesting feature of this spectrum is the presence of a 
series of fragment ion peaks that appear to be deriva- 
tives of the [Orn,Gly + CH,-4H + Fe”‘]- fragment ion 
and result from consecutive losses of water (at m/z 
6061, ketene (m/z 562), and methanol (at m/z 529) 
molecules. All three of these peaks lack ferric ion (the 
excess of the negative charge is probably compensated 
by the intramolecular proton transfers during dissocia- 
tion). These observations provide further reinforcement 
to the conclusion that hydroxamate oxygen atoms play 
an important role in stabilizing the ferric ion within the 
peptide, and that the metal ion chelation cannot be 
carried effectively by the heteroatoms of the peptide 
backbone. 
Ferrichrome has been also subjected to the mass 
spectral analysis using matrix-assisted laser desorption 
ionization (MALDI) in this work. MALDI is only rarely 
used to study specific noncovalent interactions of bi- 
omolecules 1171 primarily due to extreme pK, values of 
most UV matrices employed to facilitate ion desorption. 
Nevertheless, because the typical MALDI conditions 
are generally considered to be rather “soft,” compared 
to that of LSIMS, we have expected the metal ion- 
peptide complex to survive desorption by MALDI. It 
came as a surprise to us that the intact ferrichrome 
appeared to be rather fragile under conditions of 
MALDI. Although protonated ferrichrome [M-2H + 
Fe”‘]+ is present in the positive ion MALDI spectra, its 
intensity is significantly lower compared to that of the 
analyte ions lacking Fe’=, [M + Na]+ in particular 
(Figure 8a). It must be noted that the ion intensity ratio 
[M-2H + Fem]‘/[M + Na]+ increases when the laser 
irradiation power is lowered. In fact, [M-2H + Fei”]’ 
was determined to be a predominant high-mass ion in 
the linear mode experiments, which are performed at 
much lower laser output, as compared to the reflectron 
mode (data not shown). The three most abundant ion 
peaks in the low-mass region of the spectrum (Figure 
8a) are those of Na+, Fe*+, and K+. ISodium and 
potassium cations are ubiquitous contaminants and are 
usually prominent in all MALDI spectra. Abundances 
of other metal anions in MALDI spectra are usually at 
least an order of magnitude lower that of lVa+ and K+. 
In our case, the signal intensity of the Fe’+ peak is close 
to that of Na+ and exceeds K+. Therefore, it seems to be 
very likely that the observed anomalously high ionic 
signal of Fe*+ could be a result of dissociation of a 
reduced, Fe”-containing ferrichrome cation. This as- 
sumption is further supported by the fact that no Fe3+ 
ionic signal has been detected. 
The anions of the intact ferrichrome are missing in 
the negative ion MALDI spectrum altogether (Figure 
8b), the most prominent high-mass ion being [M-H]-. It 
appears that acidic matrices used in MALDI facilitate 
the reduction process of Fe”’ to Fen and /or catalyze 
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Figure 8. (a) Positive and (b) negative ion MALDI mass spectra 
of HPLC-purified ferrichrome. 
dissociation of iron from ferrichrome (e.g., by protonat- 
ing the negatively charged hydroxamate groups). 
Conclusions 
Ferrichrome, a complex of a cyclic peptide and Fe’“, 
appears to be remarkably stable under conditions of 
LSIMS. Reduction of ferric ion to ferrous ion within the 
metal-peptide complex does not necessarily result in 
dissociation of the complex. The stability of the metal 
ion-peptide complex is significantly lower under typical 
MALDI conditions, presumably due to the influence of 
acidic matrices. The appearance of high-energy CID 
spectra of ferrichrome cation, generated by LSIMS, 
suggests that Fe”’ is still coordinated by hydroxamate 
oxygen atoms of the ornithine side chains in the gas 
phase, just as in solution or crystal. A minimum of four 
oxygen atoms is required to chelate the ferric ion. This 
chelation is rather specific, as heteroatoms of the pep- 
tide backbone do not appear to be able to coordinate 
effectively the metal ion when the number of available 
hydroxamate oxygen donors is reduced by fragmenting 
the peptide. 
This work was supported in part by the National Institutes of 
Health grant no. ROlGM33967. 
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